Non disponible en dehors du Royaume-Uni et de l'Irlande
Application
Concanamycin A has been used: as a lysosomal inhibitor in young and old fibroblasts as a vacuolar-type H+-ATPase inhibitor in presynaptic vesiclesas a lysosomal acidification blocker in HepG2 hepatocytes cells
Biochem/physiol Actions
Concanamycin A (ConA) inhibits acidification of organelles and perforin-mediated cytotoxicity. It is a vacuolar-type v-ATPase inhibitor. ConA possesses antiprotozoal and antineoplastic properties. It mediates inhibition of the negative factor (Nef) protein of the human immunodeficiency virus.
General description
Chemical structure: macrolide
Concanamycin A belongs to the plecomacrolide family and comprises an 18-membered tetraenic macrolide ring.
Ce produit répond aux critères suivants pour être admissible aux récompenses suivantes :